NCT04825457

Brief Summary

Endoscopic mucosal resection (EMR) is an effective and has been widely used technique for the treatment of superficial colorectal neoplasms. Although, conventional EMR (CEMR) showed high efficacy for the management of colorectal superficial neoplasms, there is problematic limitation in this technique - incomplete resection. In literature, the anchoring-tip EMR (AEMR), named as "Tip-in EMR" was first introduced in 2016 from Japan. Recently, several retrospective studies have been suggested about the effectiveness of AEMR. However, there has been no prospective randomized controlled study to identify its advantage over CEMR. Therefore, the investigators performed a multicenter randomized controlled trial to estimate the effectiveness of AEMR compared with CEMR for the endoscopic treatment of intermediate-size (10 to 20 mm) colorectal polyps.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

11 months

First QC Date

March 29, 2021

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary outcome was comparing the R0 resection rate between Anchoring-tip EMR and Conventional EMR.

    Histopathologic complete resection (R0) was defined as en bloc resection and clear lateral and vertical resection margins.

    From EMR to reporting of histopathology, 1 month

Study Arms (2)

Anchoring-tip EMR

ACTIVE COMPARATOR

AEMR, the snare tip was projected from the sheath by 1-2 mm length. Consequently, a small mucosal incision was made at proximal side of lesion. Then the snare was deployed progressively and adjusted around the lesion trying to obtain free margins.

Procedure: Anchoring-tip vs. Conventional

Conventional EMR

ACTIVE COMPARATOR

After injection of normal saline solution mix, snaring was tried for CEMR.

Procedure: Anchoring-tip vs. Conventional

Interventions

Anchoring-tip: the snare tip was projected from the sheath by 1-2 mm length. Consequently, a small mucosal incision was made at proximal side of lesion. Then the snare was deployed progressively and adjusted around the lesion trying to obtain free margins. At the final step of both conventional and Tip-in EMR, the lesion was resected. Conventional: After injection of normal saline solution mix, snaring was tried for polyp resection.

Anchoring-tip EMRConventional EMR

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intermediate-size (10 to 20 mm) colorectal polyps
  • Morphologically sessile (Is), slightly elevated (IIa), flat (IIb), and slightly depressed (IIc) as Paris classification of superficial neoplastic lesions
  • Laterally spreading tumor (granular and nongranular type) as Kudo classification.

You may not qualify if:

  • Pedunculated or excavated/ulcerated polyps
  • Polyps with features strongly suggestive of submucosal invasive carcinoma
  • Polyps in patients with inflammatory bowel disease, familial polyposis, electrolyte abnormality, and coagulopathy
  • Residual lesions after endoscopic resection or presence of severe submucosal fibrosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joon Seop Lee

Daegu, 41404, South Korea

RECRUITING

Central Study Contacts

Joon Seop Lee, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 1, 2021

Study Start

April 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations